Gemigliptin, a novel dipeptidyl peptidase 4 inhibitor: first new anti-diabetic drug in the history of Korean pharmaceutical industry

Saved in:
Bibliographic Details
Published inArchives of pharmacal research Vol. 36; no. 10; pp. 1185 - 1188
Main Authors Kim, Sung-Ho, Lee, Sung-Hack, Yim, Hyeon-Joo
Format Journal Article
LanguageEnglish
Published 01.10.2013
Online AccessGet full text

Cover

More Information
ISSN:0253-6269
1976-3786
DOI:10.1007/s12272-013-0171-x